HYPERPHOSPHAT EMIA Group 5
Outlines -Disease manifestation (symptoms,signs), pathogenesis and pathophysiology. -Plan of treatment -Brief detail on pharmacology of the individual important drugs being used.
SIGN AND SYMPTOMS
Signs and symptoms Although most patients with hyperphosphatemia are asymptomatic, they occasionally report hypocalcemic symptoms. muscle cramps tetany perioral numbness or tingling. Othebone and joint pain, pruritus, and rash
PATHOGENESIS
Pathogenesis of hyperphosphatemia Vitamin D intoxication Decreased phosphate excretion because of renal failure
Normal of phosphate homeostas is
Vitamin D intoxicat ion
Decreased phosphate excretion because of renal failure
The Treatment concept of hyperphosphatemia in CKD and phosphate binders
Management of Hyperphosphatemia High phosphate diet restriction Medication: phosphate binders Dialysis intervention: HD or PD
Management of Hyperphosphatemia Limiting dietary phosphate intake: KDOQI : Dietary phosphorus restricted to 800 to 1,000 mg/day when The serum phosphorus levels are elevated (> 4.6 in CKD S3,4 or > 5.5 in CKD S5) The plasma levels of intact PTH are elevated above target range of the CKD stage \ American Journal of Kidney Diseases 2003;42(4):S12-S28.
Management of Hyperphosphatemia
If phosphorus or intact PTH level cannot be control with the target range, despite dietary phosphorus restriction, “Phosphate binders should be prescribed.”
Management of Hyperphosphatemia
Non calcium base binder Management of Hyperphosphatemia
Calcium-based
Calcium carbonate(500 mg,750 mg, 1000 mg) -40% elemental calcium -Dosage regimens: g (elemental calcium) three times daily with meals Mechanism of action Form Insoluble complex in intestines
Calcium acetate -25% calcium element -First-line agent: comparable efficacy to calcium carbonate with half the dose of elemental calcium
Adverse effects - Anorexia - constipation - Flatulence - Nausea - vomiting - Hypercalcemia
Management of Hyperphosphatemia
Non-calcium based phosphate binder
Mechanism of action Bind phosphate in the GI tract to form insoluble complexes and reduces phosphate absorption Aluminum hydroxide
Pharmacokinetics Insoluble, poorly absorbed Al salts in the intestines: hydroxides, Carbonated, phosphates and fatty acid derivatives, are excreted in feces Adverse effects Aluminium toxicity mainly three disorders: - aluminium-induced bone disease - microcytic anemia - neurological dysfunction (encephalopathy).
- Not a first-line agent Reserve for short-term use (4 wk) in patients with hyperphosphatemia not responding to other binders
Management of Hyperphosphatemia
Sevelamer carbonate/ Sevelamer hydrochloride
Mechanism of action Amines exist in a protonated form in the intestine and interact with phosphate molecules through ionic and hydrogen bonding Lower LDL-cholesterol
Pharmacokinetics -Not systemically absorbed -Elimination: Feces Adverse effect - vomiting (22%), nausea(20%), diarrhea (19%), dyspepsea (16%) Dosage tablet(400, 800mg), powder fororal suspension (800mg, 2,400 mg)
Lanthanum carbonate
Mechanism of action form strong complexes with Phosphate that inhibits GI absorption and results in a decrease of serum phosphate and calcium levels
Dosage and indication - Chewable tablet 500, 750, 1000 mg Pharmacokinetics -Half-life, elimination: 53 hr (plasma) -Peak plasma: 1 ng/ml -Bioavailability : 0.002% -Protein bound: 99% -Metabolism : not metabolized -Excretion : Predominantly feces Adverse effect: constipation, abdominal pain, diarrhea, hypertension
Comparison of Phosphate-binding agents
Indication as phosphate-binding agents Phosphate-binding properties Calcium carbonate Calcium citrate Aluminum hydroxide Sevelamer Lantanum
Administration Phosphate-binding properties Calcium carbonateTablets Calcium citrateTablets Aluminum hydroxideSuspension SevelamerPowder for suspension, tablets LantanumTablets
Efficacy
Advantages vs disadvantages
Management of Hyperphosphatemia
Take home message
Management of Hyperphosphatemia
Members 1.ChutinunSangkanjanavanich Thosapol Jeamanukoolkit PhongsathonThongkiew FeaungpongArunrodpanya PhitchakornTangaromsuk WichittraphonSukcharoen RattaratKengkoom TharitLee